C4 Therapeutics, Inc.

📍 Watertown, United States🗓 Founded 2015👥 110 employees💰 Last funded Oct 2025
Biotechnology🌐 c4therapeutics.com
Website LinkedIn
C4 Therapeutics (C4T) (Nasdaq: CCCC) is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients’ lives. C4T is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO® platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. C4T’s degrader medicines are designed to harness the body’s natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, drug undruggable targets and improve patient outcomes.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2015
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
France
1
Frequently asked questions
Who invested in C4 Therapeutics, Inc.?
C4 Therapeutics, Inc. has 1 investors on record on gritt.io and 1 late-stage investors.
When did C4 Therapeutics, Inc. last raise funding?
The most recent investment in C4 Therapeutics, Inc. recorded on gritt.io was in October 2025.
When was C4 Therapeutics, Inc. founded?
C4 Therapeutics, Inc. was founded in 2015.
What industry is C4 Therapeutics, Inc. in?
C4 Therapeutics, Inc. operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is C4 Therapeutics, Inc. based?
C4 Therapeutics, Inc. is headquartered in Watertown, United States.